Clinical Trial Update: Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant [NA]

View source ↗

Summary

This clinical trial update reports the completion and results posting of a study evaluating pre-transplant treatment with 5-azacitidine in patients with high-ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• VIDAZA (AZACITIDINE)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Leukemia | NA | Status: COMPLETED | Results posted: 2014-07-16